New Friends Company (Chemists) Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.87 M
as on 16-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.49 Cr
as on 16-12-2024
- Revenue 43.00%
(FY 2022)
- Profit 45.28%
(FY 2022)
- Ebitda 45.90%
(FY 2022)
- Net Worth 14.55%
(FY 2022)
- Total Assets -5.50%
(FY 2022)
About New Friends Company (Chemists)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.87 M.
The company currently has active open charges totaling ₹1.49 Cr.
Sanjeev Jain and Virender Jain serve as directors at the Company.
- CIN/LLPIN
U74899DL2004PTC125524
- Company No.
125524
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at New Friends Company (Chemists)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Jain  | Director | 31-Mar-2004 | Current |
| Virender Jain | Director | 31-Mar-2004 | Current |
Financial Performance of New Friends Company (Chemists).
New Friends Company (Chemists) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43% increase. The company also saw a substantial improvement in profitability, with a 45.28% increase in profit. The company's net worth Soared by an impressive increase of 14.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Friends Company (Chemists)?
Unlock access to New Friends Company (Chemists)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 20 Jun 2021 | ₹0.75 M | Open |
Hdfc Bank Limited Creation Date: 21 Dec 2020 | ₹1.00 M | Open |
Others Creation Date: 28 Jul 2017 | ₹1.13 M | Open |
How Many Employees Work at New Friends Company (Chemists)?
Unlock and access historical data on people associated with New Friends Company (Chemists), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Friends Company (Chemists), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Friends Company (Chemists)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
